Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Hypertonic Sodium Lactate on sVCAM-1 Level as a Surrogate Marker of Endothelial Capillary Leakage in Pediatric Dengue Shock Syndrome Patients

NCT00966628 is registered in ClinicalTrials.gov with Innogene Kalbiotech Pte. Ltd as lead sponsor.

NCT NCT00966628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00966628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Hypertonic Sodium Lactate on sVCAM-1 Level as a Surrogate Marker of Endothelial Capillary Leakage in Pediatric Dengue Shock Syndrome Patients
Lead sponsor
Innogene Kalbiotech Pte. Ltd
Phase
Phase 3
Overall status
Unknown status
Start date
May 31, 2008
Completion date
December 31, 2009
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dengue shock syndrome